Wegovy HD scripts edge up 0.6% to 23,894 in the week of Oct 29
KontraInvest puts Wegovy HD's annual run rate near $0.5bn, with volume at about 40% of Foundayo's.
Recap by typeshit. Post by @KontraInvest on X.
KontraInvest puts Wegovy HD's annual run rate near $0.5bn, with volume at about 40% of Foundayo's.
Recap by typeshit. Post by @KontraInvest on X.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Avi Roy says a Chinese supplier shipped retatrutide with a purity certificate, but a buyer's own germ test came back failed. A sharp look at gray-market risks.
Pooling 4,805 people with type 2 diabetes, researchers saw about 8% weight loss at both doses, with more stomach side effects and dropouts at 2.4 mg.
Loading…